Comparative tolerability of intravenous erythromycin and clarithromycin in hospitalised patients with community-acquired pneumonia: Results of a double-blind, randomised, prospective study

Clinical Drug Investigation

Volumn 22, Issue 6, 2002, Pages 393-398

  de Celis, G ^a   Gea, E ^a   Roig, J ^a   Latorre, X ^a   Martinez Benazet J ^a   Gomez J ^a  

^a Hospital Nostra Senyora de Meritxell   (France)

Author keywords

[No Author keywords available]

Indexed keywords

CLARITHROMYCIN; ERYTHROMYCIN ETHYLSUCCINATE;

ADULT; ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DOUBLE BLIND PROCEDURE; DRUG TOLERABILITY; FEMALE; GASTROINTESTINAL SYMPTOM; HUMAN; MAJOR CLINICAL STUDY; MALE; PHLEBITIS; PNEUMONIA; PRIORITY JOURNAL; PROSPECTIVE STUDY; RANDOMIZED CONTROLLED TRIAL;

EID: 0036283177     PISSN: 11732563     EISSN: None     Source Type: Journal    
DOI: 10.2165/00044011-200222060-00007     Document Type: Article

References (28)

1. Guidelines from the Infectious Diseases Society of America. Community-acquired pneumonia in adults: Guidelines for management
2. Community-acquired pneumonia guidelines an international comparison: A view from Europe
3. Guidelines for the management of adults with community-acquired pneumonia: Diagnosis, assessment of severity, antimicrobial therapy, and prevention
4. Intravenous clarithromycin
5. Intravenous azithromycin
6. Gastrointestinal side effects of intravenous erythromycin: Incidence and reduction with prolonged infusion time and glycopyrrolate pretreatment
7. Infusion phlebitis in patients with acute pneumonia: A prospective study
8. Treatment of legionnaires' disease: Current recommendations
9. Review of macrolides and ketolides: Focus on respiratory tract infections
10. Approach to severe legionellosis
11. Comparative tolerability of intravenous azithromycin, clarithromycin and erythromycin in healthy volunteers: Results of a double-blind, double-dummy, four-way crossover study
12. Community-acquired pneumonia: Initial management and empirical treatment
13. Peripherally inserted central venous catheters: Low-risk alternatives for ongoing venous access
14. Peripherally inserted central catheters: A report of 2506 catheter days
15. Accurate placement of central venous catheters: A prospective, randomised, multicenter trial
16. Venous access: Preoperative, operative, and postoperative dilemmas
17. Central venous catheter-related sepsis in a cohort of 366 hospitalised patients
18. Efficacy of antiseptic-impregnated central venous catheters in preventing catheter-related bloodstream infection: A meta-analysis
19. The cost of treating community-acquired pneumonia
20. Oral or intravenous-to-oral antibiotic switch therapy for treating patients with community-acquired pneumonia
21. Early switch from intravenous to oral antibiotics and early hospital discharge: A prospective observational study of 200 consecutive patients with community-acquired pneumonia
22. Identification of low-risk hospitalized patients with pneumonia: Implications for early conversion to oral antimicrobial therapy
23. Antimicrobial selection for hospitalized patients with presumed community-acquired pneumonia: A survey of nonteaching US community hospitals
24. Associations between initial antimicrobial therapy and medical outcomes for hospitalized elderly patients with pneumonia
25. Medical outcomes and antimicrobial costs with the use of the American Thoracic Society guidelines for outpatients with community-acquired pneumonia
26. Effect of macrolides as part of initial empiric therapy on length of stay in patients hospitalised with community-acquired pneumonia
27. Bacteremic pneumococcal pneumonia in one American city: A 20-year longitudinal study, 1978-1997
28. Monotherapy may be suboptimal for severe bacteremic pneumococcal pneumonia